Meltz Mark A 4
4 · Kinnate Biopharma Inc. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Meltz Mark A
COO General Counsel Treasurer
Transactions
- Tax Payment
Common Stock
2022-12-01$7.75/sh−541$4,193→ 27,924 total
Footnotes (1)
- [F1]Includes 23,438 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.